StockData
Abeona Therapeutics Inc. logo

Abeona Therapeutics Inc. (ABEO) stock

ABEONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3027% below fair value
$2.73+0.13 (+5.00%)

Close on Nov 18, 2026Market cap $156.11MP/E –Yield –

Abeona Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Abeona Therapeutics's pe ratio was 6.5× on Jul 31, 2026, against 7.7× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jul 31, 20266.5×+3.1
2025Dec 31, 20253.4×−4.4
2014Apr 30, 20147.7×+7.5
2013Dec 31, 20130.3×–

More Abeona Therapeutics figures

See a number that looks wrong?